<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00243919</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00006846</org_study_id>
    <secondary_id>R01NS050506</secondary_id>
    <nct_id>NCT00243919</nct_id>
  </id_info>
  <brief_title>Locomotor Experience Applied Post Stroke Trial</brief_title>
  <acronym>LEAPS</acronym>
  <official_title>Locomotor Experience Applied Post Stroke (LEAPS) Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare two different treatments to improve walking after
      stroke (or post-stroke).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The impact of stroke on walking is significant, with only 37 percent of stroke survivors able
      to walk after the first week after stroke (or post-stroke). Even among those who achieve
      independent ambulation, significant residual deficits persist in balance and gait speed with
      a 73 percent incidence of falls among individuals with mild to moderate impairment 6 months
      post-stroke. Body weight supported treadmill training is one therapeutic method for locomotor
      training that is rapidly being adopted into physical rehabilitation to improve walking after
      stroke.

      The purpose of this multi-center, randomized controlled study is to compare two different
      treatments to improve walking after stroke. The two treatments are: 1) a training program
      that includes use of a body weight support system and a treadmill to practice walking and 2)
      a physical therapist monitored exercise program to work on general conditioning and
      strengthening in the patient's home. In addition, investigators will determine the best time
      to provide training after a stroke and if the training is beneficial for mild, moderate, or
      severe cases of stroke.

      Four hundred subjects will be recruited from five facilities in Florida and California.
      Screening and subject recruitment will take place within 45 days post-stroke. All stroke
      patients will be screened to determine eligibility for the study. Eligible subjects will be
      followed for 2 months post-stroke. At that time, those who are eligible for enrollment and
      who consent to participate will undergo an exercise tolerance test and baseline assessment.
      Following this evaluation, participants will be randomized into one of three groups,
      according to the severity of their locomotor impairment: early locomotor, late locomotor, or
      early home exercise.

      The early locomotor training group will begin the locomotor training program immediately (2
      months post stroke). The locomotor training program is an out-patient program of locomotor
      training for 36 sessions, 3 times per week, using a body weight support system and stepping
      on a treadmill. The late locomotor training group will begin locomotor training at 6 months
      post-stroke. Participants in the early home exercise group will receive a non-specific low
      intensity exercise program beginning immediately (2 months post stroke).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Patients Who Successfully Improved Functional Level of Walking at 1 Year Post-stroke</measure>
    <time_frame>12 months post-stroke</time_frame>
    <description>Success: walking greater than 0.4 m/sec if baseline was less than 0.4; walking greater than 0.8 m/sec if baseline was 0.4m/sec or greater but less than 0.8 m/sec as measured during 10 meter walk.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Walking Speed: Measured During a 10-meter Walk</measure>
    <time_frame>Baseline and 12 months post-stroke</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Patients Who Successfully Improved Functional Level of Walking at 6 Months Post-stroke</measure>
    <time_frame>Baseline and 6 months post-stroke</time_frame>
    <description>Success: walking greater than 0.4 m/sec if baseline was less than 0.4; walking greater than 0.8 m/sec if baseline was 0.4m/sec or greater but less than 0.8 m/sec as measured during 10 meter walk.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 Month Outcome: Walking Speed: Measured During a 10-meter Walk</measure>
    <time_frame>Baseline and 6 months post-stroke</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 Minute Walking Distance (Meters)</measure>
    <time_frame>Baseline, 6 months and 12 months post-stroke</time_frame>
    <description>Distance walked in 6 minutes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Step Activity Monitor (SAM)- Median of Average Number of Steps Per Day</measure>
    <time_frame>Baseline, 6 months and 12 months post-stroke</time_frame>
    <description>As measured with a step activity monitor averaged over 2 days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke Impact Scale (SIS) - Participation</measure>
    <time_frame>Baseline, 6 months and 12 months post-stroke</time_frame>
    <description>Range = 0 - 100. The Stroke Impact Scale is a measure of function (including ADL-IADL and mobility) and quality of life (participation). The Participation Scale is a single domain of the Stroke Impact Scale in which participation is defined as the ability to engage in meaningful activities with 0 indicating inability to engage in any meaningful activities and 100 indicating the ability to fully engage in meaningful activities.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke Impact Scale (SIS) - Activities of Daily Living/Instrumental Activities of Daily Living (ADL/IADL)</measure>
    <time_frame>Baseline, 6 months and 12 months post-stroke</time_frame>
    <description>Range 0 - 100 The Stroke Impact Scale (SIS) is a measure of function including ADL/IADL. The ADL/IADL scale is a single domain of the Stroke Impact Scale in which ADL is defined as the ability to take care of basic needs and IADL is defined as the ability to perform activities that make it possible to live independently in the community, with 0 indicating complete dependence on others and 100 indicating the ability to live independently without difficulty.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke Impact Scale (SIS) - Mobility</measure>
    <time_frame>Baseline, 6 months and 12 months post-stroke</time_frame>
    <description>Range = 0 - 100. The Stroke Impact Scale (SIS) is a measure of function including Mobility. The Mobility scale is a single domain of the Stroke Impact Scale which captures the ability to balance and move, with 0 indicating severe restrictions in balance and mobility and 100 indicating independence in mobility and balance.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fugl-Meyer Lower Extremity Score</measure>
    <time_frame>Baseline, 6 months and 12 months post-stroke</time_frame>
    <description>Range 0 - 34 The Fugl-Meyer Lower Extremity Score measures your ability to move the lower extremity with 0 indicating no movement and 34 indicating the ability to selectively move the lower extremity without difficulty.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Berg Balance Score</measure>
    <time_frame>Baseline, 6 months and 12 months post-stroke</time_frame>
    <description>Range = 0 - 56 The Berg Balance Score assesses balance in sitting, standing, reaching, shifting weight and turning, with 0 defined as inability to balance and 56 defined as the ability to balance independently and without difficulty while performing each task.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activities Specific Balance Confidence (ABC) Score</measure>
    <time_frame>Baseline, 6 months and 12 months post-stroke</time_frame>
    <description>Range = 0 - 100 The ABC scale is a self reported measure of confidence with activities such as walking around the house, standing on a chair to reach or getting out of a car without losing balance or becoming unsteady. A score of 0 indicates no confidence that the activities can be performed without losing balance and a score 100 indicates confidence that the activities can be accomplished without losing balance.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">408</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Early Locomotor Training Program</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>body weight supported training program with treadmill</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Late Locomotor Training Program</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>body weight supported training program with treadmill</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Early Home Exercise Program</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>a non-specific low intensity exercise program</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Early locomotor training program</intervention_name>
    <description>The early locomotor training program is an out-patient program of locomotor training for 36 sessions, 3 times per week, using a body weight support system and stepping on a treadmill and overground training beginning at 2 months post-stroke.</description>
    <arm_group_label>Early Locomotor Training Program</arm_group_label>
    <other_name>E-LTP</other_name>
    <other_name>LTP-early</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Late locomotor training program</intervention_name>
    <description>The late locomotor training program is an out-patient program of locomotor training for 36 sessions, 3 times per week, using a body weight support system and stepping on a treadmill and overground training beginning at 6 months post-stroke.</description>
    <arm_group_label>Late Locomotor Training Program</arm_group_label>
    <other_name>L-LTP</other_name>
    <other_name>LTP-late</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Home Exercise Program</intervention_name>
    <description>Participants in the early home exercise group will receive a non-specific low intensity exercise program beginning at 2 months post stroke.</description>
    <arm_group_label>Early Home Exercise Program</arm_group_label>
    <other_name>HEP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;/=18

          -  Stroke within 45-days

          -  Residual paresis in the lower extremity (fugl-meyer le motor score &lt; 34)

          -  Ability to sit unsupported for 30 seconds

          -  Ability to walk at least 10 feet with maximum 1 person assist

          -  Ability to follow a three step command

          -  Provision of informed consent

          -  A self-selected 10 meter gait speed less than 0.8 m/s at the 2-month post-stroke
             assessment

          -  Successful completion of an exercise tolerance test

        Exclusion Criteria:

          -  Lived in nursing home prior to stroke

          -  Unable to ambulate at least 150 feet prior to stroke, or experienced intermittent
             claudication while walking less than 200 meters

          -  Serious cardiac conditions (history of congestive heart failure, documented serious
             and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis,
             angina or dyspnea at rest or during activities of daily living). Anyone meeting New
             York Heart Association criteria for Class 3 or Class 4 heart disease will be excluded

          -  History of serious chronic obstructive pulmonary disease or oxygen dependence

          -  Severe weight bearing pain

          -  Preexisting neurological disorders such as Parkinson's disease, Amyotrophic Lateral
             Sclerosis (ALS), Multiple Sclerosis (MS), dementia, or previous stroke with residual
             neurological deficits

          -  History of major head trauma

          -  Lower extremity amputation

          -  Non-healing ulcers on the lower extremity

          -  Renal dialysis or end stage liver disease

          -  Legal blindness or severe visual impairment

          -  A history of significant psychiatric illness defined by diagnosis of bipolar affective
             disorder, psychosis, schizophrenia or medication refractory depression

          -  Life expectancy less than one year

          -  Severe arthritis or orthopedic problems that limit passive ranges of motion of lower
             extremity (knee flexion contracture of -10째, knee flexion Range of Motion (ROM) &lt; 90째,
             hip flexion contracture &gt; 25째, and ankle plantar flexion contracture &gt; 15째

          -  History of sustained alcoholism or drug abuse in the last six months

          -  Major post-stroke depression as measured by the Patient Health Questionnaire(PHQ-9 &gt;/=
             10) that is not medically managed with antidepressant medication and/or psychotherapy

          -  History of pulmonary embolism within 6 months

          -  Uncontrollable diabetes with recent weight loss, diabetic coma, or frequent insulin
             reactions

          -  Severe hypertension with systolic greater than 200 mmHg and diastolic greater than 110
             mmHg at rest,

          -  Previous or current enrollment in a clinical trial to enhance stroke motor recovery

          -  Lives more than 50 miles from the training sites

          -  Unable to travel 3 times per week for outpatient training programs

          -  Intracranial hemorrhage related to aneurysmal rupture or an arteriovenous malformation
             (hemorrhagic infarctions will not be excluded)

        Inclusion and exclusion criteria will be determined by a chart review, depression screen
        and subject interview by study physician or study coordinator. After initial chart and
        subject interview, each subject's treating physician will be asked to review inclusion and
        exclusion criteria and provide a letter supporting inclusion in the study. All subjects who
        meet selection criteria must successfully complete an exercise tolerance test
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pamela W. Duncan, PhD, PT, FAPTA, FAHA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor and Bette Busch Maniscalco, Doctor of Physical Therapy Division, Research Fellow, Department of Community and Family Medicine, Duke Center for Clinical Health Policy Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Katherine J. Sullivan, Ph.D., PT</last_name>
    <role>Principal Investigator</role>
    <affiliation>Co-Principal Investigator, Division of Biokinesiology and Physical Therapy, University of Southern California, Los Angeles, California</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrea L. Behrman, Ph.D., PT</last_name>
    <role>Principal Investigator</role>
    <affiliation>Co-Principal Investigator, Department of Physical Therapy, Brooks Center for Rehabilitation Studies, University of Florida, and Department of Veteran Affairs Brain Rehabilitation Research Center, Gainesville, Florida</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stanley P. Azen, Ph.D.,</last_name>
    <role>Study Director</role>
    <affiliation>Director Data Management Core, Biostatistics Division, Department of Preventive Medicine, University of Southern California, Los Angeles, California</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Samuel S. Wu, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Lead Biostatistician - Investigator, Department of Epidemiology and Health Policy Research, University of Florida</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bruce H. Dobkin, MD</last_name>
    <role>Study Director</role>
    <affiliation>Investigator, Department of Neurology, University of California, Los Angeles, California</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephen E. Nadeau, MD</last_name>
    <role>Study Director</role>
    <affiliation>Investigator, Geriatric Research, Education and Clinical Center and the Brain Rehabilitation Research Center, Gainesville VA Medical Center, and the Department of Neurology, University of Florida College of Medicine, Gainesville, Fl</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centinela Freeman Memorial Hospital</name>
      <address>
        <city>Inglewood</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Long Beach Memorial Hospital</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Southern California - PT Associates</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sharp Memorial Rehabilitation Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brooks Rehabilitation Hospital</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Florida Hospital</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University (Administrative Coordinating Center)</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2005</study_first_submitted>
  <study_first_submitted_qc>October 24, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 25, 2005</study_first_posted>
  <results_first_submitted>March 29, 2011</results_first_submitted>
  <results_first_submitted_qc>September 8, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 22, 2011</results_first_posted>
  <last_update_submitted>July 9, 2014</last_update_submitted>
  <last_update_submitted_qc>July 9, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 16, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>locomotor</keyword>
  <keyword>exercise</keyword>
  <keyword>walking</keyword>
  <keyword>training program</keyword>
  <keyword>body weight support training</keyword>
  <keyword>physical therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited from 6 inpatient rehabilitation centers in California and Florida from April 2006 through June 2009.</recruitment_details>
      <pre_assignment_details>Participants admitted for inpatient rehabilitation were screened by chart review. Eligible participants with first-time stroke received a comprehensive medical record review and physical and cognitive screening. At 2-months, those who maintained eligibility and successfully completed an exercise tolerance test were enrolled.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Early Locomotor Training Program</title>
          <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 2 months post-stroke.</description>
        </group>
        <group group_id="P2">
          <title>Late Locomotor Training Program</title>
          <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 6 months post-stroke.</description>
        </group>
        <group group_id="P3">
          <title>Home Exercise Program</title>
          <description>Home Exercise Program (HEP) was designed as an active control. The exercise program was progressed by a study physical therapist in the home to enhance flexibility, joint range of motion, upper- and lower-extremity strength, coordination and static and dynamic balance. Subjects were encouraged to walk daily. The home exercise program was delivered at 2 months post-stroke.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="139"/>
                <participants group_id="P2" count="143"/>
                <participants group_id="P3" count="126"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="122"/>
                <participants group_id="P2" count="125"/>
                <participants group_id="P3" count="115"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="18"/>
                <participants group_id="P3" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Administrative Error</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Early Locomotor Training Program</title>
          <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 2 months post-stroke.</description>
        </group>
        <group group_id="B2">
          <title>Late Locomotor Training Program</title>
          <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 6 months post-stroke.</description>
        </group>
        <group group_id="B3">
          <title>Home Exercise Program</title>
          <description>HEP was designed as an active control. The exercise program was progressed by a study physical therapist in the home to enhance flexibility, joint range of motion, upper- and lower-extremity strength, coordination and static and dynamic balance. Subjects were encouraged to walk daily. The home exercise program was delivered at 2 months post-stroke.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="139"/>
            <count group_id="B2" value="143"/>
            <count group_id="B3" value="126"/>
            <count group_id="B4" value="408"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.1" spread="12.3"/>
                    <measurement group_id="B2" value="63.3" spread="12.5"/>
                    <measurement group_id="B3" value="62.6" spread="13.3"/>
                    <measurement group_id="B4" value="62.0" spread="12.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54"/>
                    <measurement group_id="B2" value="69"/>
                    <measurement group_id="B3" value="61"/>
                    <measurement group_id="B4" value="184"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="85"/>
                    <measurement group_id="B2" value="74"/>
                    <measurement group_id="B3" value="65"/>
                    <measurement group_id="B4" value="224"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="22"/>
                    <measurement group_id="B4" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="113"/>
                    <measurement group_id="B2" value="128"/>
                    <measurement group_id="B3" value="104"/>
                    <measurement group_id="B4" value="345"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="81"/>
                    <measurement group_id="B2" value="77"/>
                    <measurement group_id="B3" value="78"/>
                    <measurement group_id="B4" value="236"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Time since stroke to randomization - days</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.1" spread="8.3"/>
                    <measurement group_id="B2" value="64.18" spread="9.0"/>
                    <measurement group_id="B3" value="62.9" spread="8.0"/>
                    <measurement group_id="B4" value="63.8" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Side of involvement</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Left Hemiparesis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="58"/>
                    <measurement group_id="B3" value="61"/>
                    <measurement group_id="B4" value="182"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Right Hemiparesis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="76"/>
                    <measurement group_id="B2" value="85"/>
                    <measurement group_id="B3" value="65"/>
                    <measurement group_id="B4" value="226"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Stroke Type</title>
          <description>Based on CT/MRI overread by study neurologists.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Large Vessel</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="47"/>
                    <measurement group_id="B4" value="162"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lacune</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="43"/>
                    <measurement group_id="B4" value="128"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hemorrhage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Undefined</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Modified Rankin Scale</title>
          <description>Global measure of stroke disability</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Rankin 0 - 1 (no significant disability)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Rankin 2 (slight disability)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Rankin 3 (moderate disability)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66"/>
                    <measurement group_id="B2" value="57"/>
                    <measurement group_id="B3" value="49"/>
                    <measurement group_id="B4" value="172"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Rankin 4 (moderately severe disability)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61"/>
                    <measurement group_id="B2" value="63"/>
                    <measurement group_id="B3" value="56"/>
                    <measurement group_id="B4" value="180"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Comorbidities</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Cardiovascular</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="37"/>
                    <measurement group_id="B4" value="109"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypertension</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="116"/>
                    <measurement group_id="B2" value="111"/>
                    <measurement group_id="B3" value="104"/>
                    <measurement group_id="B4" value="331"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Peripheral vascular disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chronic Obstructive Pulmonary Disease (COPD)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arthritis/other musculoskeletal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                    <measurement group_id="B2" value="52"/>
                    <measurement group_id="B3" value="47"/>
                    <measurement group_id="B4" value="146"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diabetes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="43"/>
                    <measurement group_id="B4" value="141"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Depression (Personal Health Questionnaire-9 &gt;= 10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mini Mental Status Exam</title>
          <description>Higher Score is Better;Range = 0-30</description>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.0" spread="3.2"/>
                    <measurement group_id="B2" value="26.2" spread="3.7"/>
                    <measurement group_id="B3" value="26.0" spread="3.6"/>
                    <measurement group_id="B4" value="26.1" spread="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Walking Speed (m/sec)</title>
          <description>Comfortable walking speed assessed by 10 meter walk.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Severe Disability (&lt;0.4 m/sec)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75"/>
                    <measurement group_id="B2" value="77"/>
                    <measurement group_id="B3" value="66"/>
                    <measurement group_id="B4" value="218"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moderate Disability (0.4 - 0.8 m/sec)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="66"/>
                    <measurement group_id="B3" value="60"/>
                    <measurement group_id="B4" value="190"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Comfortable walking speed (m/sec)</title>
          <description>Assessed with 10 meter walk test.</description>
          <units>m/sec</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.36" spread="0.22"/>
                    <measurement group_id="B2" value="0.38" spread="0.23"/>
                    <measurement group_id="B3" value="0.39" spread="0.22"/>
                    <measurement group_id="B4" value="0.38" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Patients Who Successfully Improved Functional Level of Walking at 1 Year Post-stroke</title>
        <description>Success: walking greater than 0.4 m/sec if baseline was less than 0.4; walking greater than 0.8 m/sec if baseline was 0.4m/sec or greater but less than 0.8 m/sec as measured during 10 meter walk.</description>
        <time_frame>12 months post-stroke</time_frame>
        <population>Intention to treat analysis. Missing data were imputed using the LOCF method.</population>
        <group_list>
          <group group_id="O1">
            <title>Early Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 2 months post-stroke.</description>
          </group>
          <group group_id="O2">
            <title>Late Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 6 months post-stroke.</description>
          </group>
          <group group_id="O3">
            <title>Home Exercise Program</title>
            <description>HEP was designed as an active control. The exercise program was progressed by a study physical therapist in the home to enhance flexibility, joint range of motion, upper- and lower-extremity strength, coordination and static and dynamic balance. Subjects were encouraged to walk daily. The home exercise program was delivered at 2 months post-stroke.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Patients Who Successfully Improved Functional Level of Walking at 1 Year Post-stroke</title>
          <description>Success: walking greater than 0.4 m/sec if baseline was less than 0.4; walking greater than 0.8 m/sec if baseline was 0.4m/sec or greater but less than 0.8 m/sec as measured during 10 meter walk.</description>
          <population>Intention to treat analysis. Missing data were imputed using the LOCF method.</population>
          <units>percent of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
                <count group_id="O2" value="143"/>
                <count group_id="O3" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.4"/>
                    <measurement group_id="O2" value="53.8"/>
                    <measurement group_id="O3" value="51.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Logistic regression was used to compare the proportion of participants who improved functional level of walking between Early-LTP and HEP adjusting for pre-specified covariates (severity of impairment, clinical site, age, stroke type, side of hemiparesis and depression). Assuming that 30% of HEP participants would improve functional level of walking, we derived a sample size of 400 to detect a clinically relevant 20% effect size with 85% power, adjusting for an loss-to-follow-up rate of 15%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.481</p_value>
            <p_value_desc>The trial tested the superiority of LTP delivered early or late, compared to HEP, using a two-sided significance level of 0.05. The study-wide error rate was controlled by applying the Hochberg step-up procedure to the two primary comparisons.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.831</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.497</ci_lower_limit>
            <ci_upper_limit>1.391</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Logistic regression was used to compare the proportion of participants who improved functional level of walking between Late-LTP and HEP adjusting for pre-specified covariates (severity of impairment, clinical site, age, stroke type, side of hemiparesis and depression).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.501</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.192</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.715</ci_lower_limit>
            <ci_upper_limit>1.985</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Walking Speed: Measured During a 10-meter Walk</title>
        <time_frame>Baseline and 12 months post-stroke</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Early Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 2 months post-stroke.</description>
          </group>
          <group group_id="O2">
            <title>Late Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 6 months post-stroke.</description>
          </group>
          <group group_id="O3">
            <title>Home Exercise Program</title>
            <description>HEP was designed as an active control. The exercise program was progressed by a study physical therapist in the home to enhance flexibility, joint range of motion, upper- and lower-extremity strength, coordination and static and dynamic balance. Subjects were encouraged to walk daily. The home exercise program was delivered at 2 months post-stroke.</description>
          </group>
        </group_list>
        <measure>
          <title>Walking Speed: Measured During a 10-meter Walk</title>
          <units>m/sec</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
                <count group_id="O2" value="143"/>
                <count group_id="O3" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.37" spread="0.22"/>
                    <measurement group_id="O2" value="0.38" spread="0.23"/>
                    <measurement group_id="O3" value="0.39" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-month change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.23" spread="0.20"/>
                    <measurement group_id="O2" value="0.24" spread="0.23"/>
                    <measurement group_id="O3" value="0.25" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The second primary analysis assessed the timing effect and its interaction with initial severity of gait impairment on walking speed change from baseline to 1 year after stroke.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.242</p_value>
            <p_value_desc>We did not formally conduct statistical inference on the timing effect because the first primary null hypotheses is accepted. The p-value provided is the smallest alpha level that one would claim significant difference between early- and late-LTP.</p_value_desc>
            <method>Regression, Linear</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.01</param_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Even though there was no formal inference of timing effect, we still provided descriptive statistics for the 6-month and 12-month changes. In addition, paired t-tests were used to compare within-group improvements.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Patients Who Successfully Improved Functional Level of Walking at 6 Months Post-stroke</title>
        <description>Success: walking greater than 0.4 m/sec if baseline was less than 0.4; walking greater than 0.8 m/sec if baseline was 0.4m/sec or greater but less than 0.8 m/sec as measured during 10 meter walk.</description>
        <time_frame>Baseline and 6 months post-stroke</time_frame>
        <population>Intention to treat analysis. Missing data were imputed using the Last Observation Carried Forward (LOCF) method.</population>
        <group_list>
          <group group_id="O1">
            <title>Early Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 2 months post-stroke.</description>
          </group>
          <group group_id="O2">
            <title>Late Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 6 months post-stroke.</description>
          </group>
          <group group_id="O3">
            <title>Home Exercise Program</title>
            <description>HEP was designed as an active control. The exercise program was progressed by a study physical therapist in the home to enhance flexibility, joint range of motion, upper- and lower-extremity strength, coordination and static and dynamic balance. Subjects were encouraged to walk daily. The home exercise program was delivered at 2 months post-stroke.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Patients Who Successfully Improved Functional Level of Walking at 6 Months Post-stroke</title>
          <description>Success: walking greater than 0.4 m/sec if baseline was less than 0.4; walking greater than 0.8 m/sec if baseline was 0.4m/sec or greater but less than 0.8 m/sec as measured during 10 meter walk.</description>
          <population>Intention to treat analysis. Missing data were imputed using the Last Observation Carried Forward (LOCF) method.</population>
          <units>percent of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
                <count group_id="O2" value="143"/>
                <count group_id="O3" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.4"/>
                    <measurement group_id="O2" value="32.2"/>
                    <measurement group_id="O3" value="49.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Logistic regression was used to compare the proportion of participants who improved functional level of walking between early-LTP and Late-LTP (Usual Care) adjusting for pre-specified covariates (severity of impairment, clinical site, age, stroke type, side of hemiparesis and depression).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.010</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Pairwise comparisons were conducted: Early-LTP versus Late-LTP, which had received only usual care in the 2- to 6-month post-stroke period.</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.94</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.18</ci_lower_limit>
            <ci_upper_limit>3.21</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Logistic regression was used to compare the proportion of participants who improved functional level of walking between HEP and Late-LTP (Usual Care) adjusting for pre-specified covariates (severity of impairment, clinical site, age, stroke type, side of hemiparesis and depression).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.007</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Pairwise comparisons were conducted: HEP versus Late-LTP, which had received only usual care in the 2- to 6-month post-stroke period.</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.04</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.22</ci_lower_limit>
            <ci_upper_limit>3.42</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>6 Month Outcome: Walking Speed: Measured During a 10-meter Walk</title>
        <time_frame>Baseline and 6 months post-stroke</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Early Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 2 months post-stroke.</description>
          </group>
          <group group_id="O2">
            <title>Late Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 6 months post-stroke.</description>
          </group>
          <group group_id="O3">
            <title>Home Exercise Program</title>
            <description>HEP was designed as an active control. The exercise program was progressed by a study physical therapist in the home to enhance flexibility, joint range of motion, upper- and lower-extremity strength, coordination and static and dynamic balance. Subjects were encouraged to walk daily. The home exercise program was delivered at 2 months post-stroke.</description>
          </group>
        </group_list>
        <measure>
          <title>6 Month Outcome: Walking Speed: Measured During a 10-meter Walk</title>
          <units>m/sec</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
                <count group_id="O2" value="143"/>
                <count group_id="O3" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.37" spread="0.22"/>
                    <measurement group_id="O2" value="0.38" spread="0.23"/>
                    <measurement group_id="O3" value="0.39" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.25" spread="0.21"/>
                    <measurement group_id="O2" value="0.13" spread="0.14"/>
                    <measurement group_id="O3" value="0.23" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>6 month secondary analysis. Following the overall ANOVA test, pairwise comparison was conducted to assess differences in walking speed changes between early-LTP and late-LTP.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Bonferroni adjustment for multiple testing was used in the pair-wise comparisons of the secondary outcomes. A difference is claimed to be statistically significant when p&lt;0.0014.</p_value_desc>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.12</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.08</ci_lower_limit>
            <ci_upper_limit>0.16</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>6 month secondary analysis. Following the overall ANOVA test, pairwise comparison was conducted to assess differences in walking speed changes between HEP and late-LTP.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>Bonferroni adjustment for multiple testing was used in the pair-wise comparisons of the secondary outcomes. A difference is claimed to be statistically significant when p&lt;0.0014.</p_value_desc>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.10</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.05</ci_lower_limit>
            <ci_upper_limit>0.14</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>6 Minute Walking Distance (Meters)</title>
        <description>Distance walked in 6 minutes.</description>
        <time_frame>Baseline, 6 months and 12 months post-stroke</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Early Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 2 months post-stroke.</description>
          </group>
          <group group_id="O2">
            <title>Late Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 6 months post-stroke.</description>
          </group>
          <group group_id="O3">
            <title>Home Exercise Program</title>
            <description>HEP was designed as an active control. The exercise program was progressed by a study physical therapist in the home to enhance flexibility, joint range of motion, upper- and lower-extremity strength, coordination and static and dynamic balance. Subjects were encouraged to walk daily. The home exercise program was delivered at 2 months post-stroke.</description>
          </group>
        </group_list>
        <measure>
          <title>6 Minute Walking Distance (Meters)</title>
          <description>Distance walked in 6 minutes.</description>
          <units>meters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
                <count group_id="O2" value="143"/>
                <count group_id="O3" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="124.1" spread="77.5"/>
                    <measurement group_id="O2" value="125.7" spread="81.8"/>
                    <measurement group_id="O3" value="126.3" spread="75.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-month change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.8" spread="62.8"/>
                    <measurement group_id="O2" value="41.0" spread="47.4"/>
                    <measurement group_id="O3" value="75.9" spread="69.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-month change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.2" spread="69.4"/>
                    <measurement group_id="O2" value="79.0" spread="75.1"/>
                    <measurement group_id="O3" value="85.2" spread="72.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Primary 12 month analysis. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.45</p_value>
            <p_value_desc>Test differences across the three groups in change of 6 minute walking distance from baseline to 12-month post stroke.</p_value_desc>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>6 month secondary analysis. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>ANOVA</method>
            <method_desc>Test differences across the three groups in change of 6 minute walking distance from baseline to 6-month post stroke.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Step Activity Monitor (SAM)- Median of Average Number of Steps Per Day</title>
        <description>As measured with a step activity monitor averaged over 2 days.</description>
        <time_frame>Baseline, 6 months and 12 months post-stroke</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Early Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 2 months post-stroke.</description>
          </group>
          <group group_id="O2">
            <title>Late Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 6 months post-stroke.</description>
          </group>
          <group group_id="O3">
            <title>Home Exercise Program</title>
            <description>HEP was designed as an active control. The exercise program was progressed by a study physical therapist in the home to enhance flexibility, joint range of motion, upper- and lower-extremity strength, coordination and static and dynamic balance. Subjects were encouraged to walk daily. The home exercise program was delivered at 2 months post-stroke.</description>
          </group>
        </group_list>
        <measure>
          <title>Step Activity Monitor (SAM)- Median of Average Number of Steps Per Day</title>
          <description>As measured with a step activity monitor averaged over 2 days.</description>
          <units>steps</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
                <count group_id="O2" value="143"/>
                <count group_id="O3" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1468" lower_limit="601" upper_limit="3889"/>
                    <measurement group_id="O2" value="1664" lower_limit="647" upper_limit="3354"/>
                    <measurement group_id="O3" value="1882.5" lower_limit="905" upper_limit="3384"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-month change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1017" lower_limit="-102" upper_limit="2209"/>
                    <measurement group_id="O2" value="565.5" lower_limit="-362" upper_limit="2043"/>
                    <measurement group_id="O3" value="1357" lower_limit="84" upper_limit="3382"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-month change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="858" lower_limit="-253" upper_limit="2422"/>
                    <measurement group_id="O2" value="1022" lower_limit="-111" upper_limit="3009"/>
                    <measurement group_id="O3" value="1471" lower_limit="435" upper_limit="3481"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>12 month primary outcome. The Kruskal-Wallis procedure was used to assess differences across the three groups in number of steps taken in the community. Wilcoxon signed rank tests were used to compare within-group improvements.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.10</p_value>
            <method>Kruskal-Wallis</method>
            <method_desc>Test differences across the three groups in change of number of steps from baseline to 12-month post stroke.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>6 month secondary analysis. The Kruskal-Wallis procedure was used to assess differences across the three groups in number of steps taken in the community. Wilcoxon signed rank tests were used to compare within-group improvements.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.04</p_value>
            <method>Kruskal-Wallis</method>
            <method_desc>Test differences across the three groups in change of number of steps from baseline to 6-month post stroke.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Stroke Impact Scale (SIS) - Participation</title>
        <description>Range = 0 - 100. The Stroke Impact Scale is a measure of function (including ADLIADL and mobility) and quality of life (participation). The Participation Scale is a single domain of the Stroke Impact Scale in which participation is defined as the ability to engage in meaningful activities with 0 indicating inability to engage in any meaningful activities and 100 indicating the ability to fully engage in meaningful activities.</description>
        <time_frame>Baseline, 6 months and 12 months post-stroke</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Early Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 2 months post-stroke.</description>
          </group>
          <group group_id="O2">
            <title>Late Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 6 months post-stroke.</description>
          </group>
          <group group_id="O3">
            <title>Home Exercise Program</title>
            <description>HEP was designed as an active control. The exercise program was progressed by a study physical therapist in the home to enhance flexibility, joint range of motion, upper- and lower-extremity strength, coordination and static and dynamic balance. Subjects were encouraged to walk daily. The home exercise program was delivered at 2 months post-stroke.</description>
          </group>
        </group_list>
        <measure>
          <title>Stroke Impact Scale (SIS) - Participation</title>
          <description>Range = 0 - 100. The Stroke Impact Scale is a measure of function (including ADLIADL and mobility) and quality of life (participation). The Participation Scale is a single domain of the Stroke Impact Scale in which participation is defined as the ability to engage in meaningful activities with 0 indicating inability to engage in any meaningful activities and 100 indicating the ability to fully engage in meaningful activities.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
                <count group_id="O2" value="143"/>
                <count group_id="O3" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.0" spread="23.3"/>
                    <measurement group_id="O2" value="46.6" spread="23.0"/>
                    <measurement group_id="O3" value="44.8" spread="23.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.8" spread="26.8"/>
                    <measurement group_id="O2" value="7.7" spread="20.5"/>
                    <measurement group_id="O3" value="14.7" spread="22.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 month change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.1" spread="25.9"/>
                    <measurement group_id="O2" value="13.1" spread="22.0"/>
                    <measurement group_id="O3" value="14.4" spread="20.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>12 month primary outcome. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.48</p_value>
            <method>ANOVA</method>
            <method_desc>Test differences across the three groups in change of SIS Participation from baseline to 12-month post stroke.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>6 month secondary outcome. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.06</p_value>
            <method>ANOVA</method>
            <method_desc>Test differences across the three groups in change of SIS Participation from baseline to 6-month post stroke.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Stroke Impact Scale (SIS) - Activities of Daily Living/Instrumental Activities of Daily Living (ADL/IADL)</title>
        <description>Range 0 - 100 The Stroke Impact Scale (SIS) is a measure of function including ADL/IADL. The ADL/IADL scale is a single domain of the Stroke Impact Scale in which ADL is defined as the ability to take care of basic needs and IADL is defined as the ability to perform activities that make it possible to live independently in the community, with 0 indicating complete dependence on others and 100 indicating the ability to live independently without difficulty.</description>
        <time_frame>Baseline, 6 months and 12 months post-stroke</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Early Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 2 months post-stroke.</description>
          </group>
          <group group_id="O2">
            <title>Late Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 6 months post-stroke.</description>
          </group>
          <group group_id="O3">
            <title>Home Exercise Program</title>
            <description>HEP was designed as an active control. The exercise program was progressed by a study physical therapist in the home to enhance flexibility, joint range of motion, upper- and lower-extremity strength, coordination and static and dynamic balance. Subjects were encouraged to walk daily. The home exercise program was delivered at 2 months post-stroke.</description>
          </group>
        </group_list>
        <measure>
          <title>Stroke Impact Scale (SIS) - Activities of Daily Living/Instrumental Activities of Daily Living (ADL/IADL)</title>
          <description>Range 0 - 100 The Stroke Impact Scale (SIS) is a measure of function including ADL/IADL. The ADL/IADL scale is a single domain of the Stroke Impact Scale in which ADL is defined as the ability to take care of basic needs and IADL is defined as the ability to perform activities that make it possible to live independently in the community, with 0 indicating complete dependence on others and 100 indicating the ability to live independently without difficulty.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
                <count group_id="O2" value="143"/>
                <count group_id="O3" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.1" spread="20.1"/>
                    <measurement group_id="O2" value="55.7" spread="20.4"/>
                    <measurement group_id="O3" value="54.4" spread="20.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-month change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.8" spread="17.2"/>
                    <measurement group_id="O2" value="7.0" spread="17.8"/>
                    <measurement group_id="O3" value="13.0" spread="16.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-month change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.6" spread="19.5"/>
                    <measurement group_id="O2" value="9.4" spread="17.2"/>
                    <measurement group_id="O3" value="14.5" spread="19.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>12 month primary outcome. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.07</p_value>
            <method>ANOVA</method>
            <method_desc>Test differences across the three groups in change of SIS ADL/iADL from baseline to 12-month post stroke.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>6 month secondary outcome. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.03</p_value>
            <method>ANOVA</method>
            <method_desc>Test differences across the three groups in change of SIS ADL/iADL from baseline to 6-month post stroke.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Stroke Impact Scale (SIS) - Mobility</title>
        <description>Range = 0 - 100. The Stroke Impact Scale (SIS) is a measure of function including Mobility. The Mobility scale is a single domain of the Stroke Impact Scale which captures the ability to balance and move, with 0 indicating severe restrictions in balance and mobility and 100 indicating independence in mobility and balance.</description>
        <time_frame>Baseline, 6 months and 12 months post-stroke</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Early Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 2 months post-stroke.</description>
          </group>
          <group group_id="O2">
            <title>Late Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 6 months post-stroke.</description>
          </group>
          <group group_id="O3">
            <title>Home Exercise Program</title>
            <description>HEP was designed as an active control. The exercise program was progressed by a study physical therapist in the home to enhance flexibility, joint range of motion, upper- and lower-extremity strength, coordination and static and dynamic balance. Subjects were encouraged to walk daily. The home exercise program was delivered at 2 months post-stroke.</description>
          </group>
        </group_list>
        <measure>
          <title>Stroke Impact Scale (SIS) - Mobility</title>
          <description>Range = 0 - 100. The Stroke Impact Scale (SIS) is a measure of function including Mobility. The Mobility scale is a single domain of the Stroke Impact Scale which captures the ability to balance and move, with 0 indicating severe restrictions in balance and mobility and 100 indicating independence in mobility and balance.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
                <count group_id="O2" value="143"/>
                <count group_id="O3" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.0" spread="22.1"/>
                    <measurement group_id="O2" value="60.5" spread="20.7"/>
                    <measurement group_id="O3" value="59.1" spread="19.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-month change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.3" spread="21.4"/>
                    <measurement group_id="O2" value="7.0" spread="15.7"/>
                    <measurement group_id="O3" value="14.9" spread="20.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-month change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.7" spread="21.6"/>
                    <measurement group_id="O2" value="12.0" spread="19.1"/>
                    <measurement group_id="O3" value="14.2" spread="20.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>12 month primary outcome. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.69</p_value>
            <method>ANOVA</method>
            <method_desc>Test differences across the three groups in change of SIS Mobility from baseline to 12-month post stroke.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>6 month secondary outcome. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <method>ANOVA</method>
            <method_desc>Test differences across the three groups in change of SIS Mobility from baseline to 6-month post stroke.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fugl-Meyer Lower Extremity Score</title>
        <description>Range 0 - 34 The Fugl-Meyer Lower Extremity Score measures your ability to move the lower extremity with 0 indicating no movement and 34 indicating the ability to selectively move the lower extremity without difficulty.</description>
        <time_frame>Baseline, 6 months and 12 months post-stroke</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Early Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 2 months post-stroke.</description>
          </group>
          <group group_id="O2">
            <title>Late Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 6 months post-stroke.</description>
          </group>
          <group group_id="O3">
            <title>Home Exercise Program</title>
            <description>HEP was designed as an active control. The exercise program was progressed by a study physical therapist in the home to enhance flexibility, joint range of motion, upper- and lower-extremity strength, coordination and static and dynamic balance. Subjects were encouraged to walk daily. The home exercise program was delivered at 2 months post-stroke.</description>
          </group>
        </group_list>
        <measure>
          <title>Fugl-Meyer Lower Extremity Score</title>
          <description>Range 0 - 34 The Fugl-Meyer Lower Extremity Score measures your ability to move the lower extremity with 0 indicating no movement and 34 indicating the ability to selectively move the lower extremity without difficulty.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
                <count group_id="O2" value="143"/>
                <count group_id="O3" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.7" spread="6.7"/>
                    <measurement group_id="O2" value="24.8" spread="6.4"/>
                    <measurement group_id="O3" value="24.7" spread="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-month change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="3.4"/>
                    <measurement group_id="O2" value="1.3" spread="3.3"/>
                    <measurement group_id="O3" value="2.4" spread="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-month change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" spread="3.9"/>
                    <measurement group_id="O2" value="1.5" spread="3.7"/>
                    <measurement group_id="O3" value="2.5" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>12 month primary analysis. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.13</p_value>
            <method>ANOVA</method>
            <method_desc>Test differences across the three groups in change of FM-LE from baseline to 12-month post stroke.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>6 month secondary analysis. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.04</p_value>
            <method>ANOVA</method>
            <method_desc>Test differences across the three groups in change of FM-LE from baseline to 6-month post stroke.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Berg Balance Score</title>
        <description>Range = 0 - 56 The Berg Balance Score assesses balance in sitting, standing, reaching, shifting weight and turning, with 0 defined as inability to balance and 56 defined as the ability to balance independently and without difficulty while performing each task.</description>
        <time_frame>Baseline, 6 months and 12 months post-stroke</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Early Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 2 months post-stroke.</description>
          </group>
          <group group_id="O2">
            <title>Late Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 6 months post-stroke.</description>
          </group>
          <group group_id="O3">
            <title>Home Exercise Program</title>
            <description>HEP was designed as an active control. The exercise program was progressed by a study physical therapist in the home to enhance flexibility, joint range of motion, upper- and lower-extremity strength, coordination and static and dynamic balance. Subjects were encouraged to walk daily. The home exercise program was delivered at 2 months post-stroke.</description>
          </group>
        </group_list>
        <measure>
          <title>Berg Balance Score</title>
          <description>Range = 0 - 56 The Berg Balance Score assesses balance in sitting, standing, reaching, shifting weight and turning, with 0 defined as inability to balance and 56 defined as the ability to balance independently and without difficulty while performing each task.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
                <count group_id="O2" value="143"/>
                <count group_id="O3" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.0" spread="14.4"/>
                    <measurement group_id="O2" value="35.9" spread="14.1"/>
                    <measurement group_id="O3" value="36.5" spread="13.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-month change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.8" spread="8.1"/>
                    <measurement group_id="O2" value="5.3" spread="7.0"/>
                    <measurement group_id="O3" value="7.9" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-month change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.0" spread="7.8"/>
                    <measurement group_id="O2" value="5.9" spread="9.1"/>
                    <measurement group_id="O3" value="8.3" spread="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>12 month primary outcome. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.06</p_value>
            <method>ANOVA</method>
            <method_desc>Test differences across the three groups in change of Berg Balance Score from baseline to 12-month post stroke.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>6 month secondary outcome. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <method>ANOVA</method>
            <method_desc>Test differences across the three groups in change of Berg Balance Score from baseline to 6-month post stroke.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Activities Specific Balance Confidence (ABC) Score</title>
        <description>Range = 0 - 100 The ABC scale is a self reported measure of confidence with activities such as walking around the house, standing on a chair to reach or getting out of a car without losing balance or becoming unsteady. A score of 0 indicates no confidence that the activities can be performed without losing balance and a score 100 indicates confidence that the activities can be accomplished without losing balance.</description>
        <time_frame>Baseline, 6 months and 12 months post-stroke</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Early Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 2 months post-stroke.</description>
          </group>
          <group group_id="O2">
            <title>Late Locomotor Training Program</title>
            <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 6 months post-stroke.</description>
          </group>
          <group group_id="O3">
            <title>Home Exercise Program</title>
            <description>HEP was designed as an active control. The exercise program was progressed by a study physical therapist in the home to enhance flexibility, joint range of motion, upper- and lower-extremity strength, coordination and static and dynamic balance. Subjects were encouraged to walk daily. The home exercise program was delivered at 2 months post-stroke.</description>
          </group>
        </group_list>
        <measure>
          <title>Activities Specific Balance Confidence (ABC) Score</title>
          <description>Range = 0 - 100 The ABC scale is a self reported measure of confidence with activities such as walking around the house, standing on a chair to reach or getting out of a car without losing balance or becoming unsteady. A score of 0 indicates no confidence that the activities can be performed without losing balance and a score 100 indicates confidence that the activities can be accomplished without losing balance.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
                <count group_id="O2" value="143"/>
                <count group_id="O3" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.6" spread="23.5"/>
                    <measurement group_id="O2" value="47.0" spread="25.4"/>
                    <measurement group_id="O3" value="44.5" spread="22.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-month change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.8" spread="20.8"/>
                    <measurement group_id="O2" value="6.2" spread="20.2"/>
                    <measurement group_id="O3" value="15.6" spread="19.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-month change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.2" spread="22.3"/>
                    <measurement group_id="O2" value="11.7" spread="22.1"/>
                    <measurement group_id="O3" value="13.9" spread="21.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>12 month primary outcome. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.62</p_value>
            <method>ANOVA</method>
            <method_desc>Test differences across the three groups in change of ABC score from baseline to 12-month post stroke.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>6 month secondary outcome. Paired t-tests were used to compare within-group improvements and ANOVA to assess differences across the three groups followed with pairwise comparisons.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>ANOVA</method>
            <method_desc>Test differences across the three groups in change of ABC score from baseline to 6-month post stroke.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Total of 10 months from point of randomization at 2 months to the 12 month final assessment.</time_frame>
      <desc>Vital signs including heart rate, blood pressure and oxygen saturation were monitored every 5 minutes during exercise interventions. In addition monthly phone calls were used to capture rehospitalizations, recurrent stroke, MI, etc.</desc>
      <group_list>
        <group group_id="E1">
          <title>Early Locomotor Training Program</title>
          <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 2 months post-stroke.</description>
        </group>
        <group group_id="E2">
          <title>Late Locomotor Training Program</title>
          <description>Stepping on a treadmill with partial body weight support and manual assistance as needed for 20-30 minutes at 2.0 mph, followed by a progressive overground walking program for 20 minutes delivered at 6 months post-stroke.</description>
        </group>
        <group group_id="E3">
          <title>Home Exercise Program</title>
          <description>HEP was designed as an active control. The exercise program was progressed by a study physical therapist in the home to enhance flexibility, joint range of motion, upper- and lower-extremity strength, coordination and static and dynamic balance. Subjects were encouraged to walk daily. The home exercise program was delivered at 2 months post-stroke.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="51" subjects_at_risk="139"/>
                <counts group_id="E2" subjects_affected="59" subjects_at_risk="143"/>
                <counts group_id="E3" subjects_affected="39" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Myocardial Infarction (MI)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="139"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="143"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization</sub_title>
                <counts group_id="E1" events="64" subjects_affected="45" subjects_at_risk="139"/>
                <counts group_id="E2" events="83" subjects_affected="53" subjects_at_risk="143"/>
                <counts group_id="E3" events="48" subjects_affected="31" subjects_at_risk="126"/>
              </event>
              <event>
                <sub_title>Limitation in activities of daily living (ADL)&gt;48hrs</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="139"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="143"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="126"/>
              </event>
              <event>
                <sub_title>Other</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="139"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="143"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="126"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="139"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="143"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Fracture</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="139"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="143"/>
                <counts group_id="E3" events="7" subjects_affected="5" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Recurrent Stroke</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="139"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="143"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="100" subjects_at_risk="139"/>
                <counts group_id="E2" subjects_affected="101" subjects_at_risk="143"/>
                <counts group_id="E3" subjects_affected="88" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Excessive hypertension during exercise that requires the intervention to be stopped for the day</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="139"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="143"/>
                <counts group_id="E3" events="11" subjects_affected="10" subjects_at_risk="126"/>
              </event>
              <event>
                <sub_title>Low blood pressure during exercise that requires intervention to be stopped for the day</sub_title>
                <counts group_id="E1" events="11" subjects_affected="8" subjects_at_risk="139"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="143"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Minor fall, no or minimal injury</sub_title>
                <counts group_id="E1" events="181" subjects_affected="76" subjects_at_risk="139"/>
                <counts group_id="E2" events="160" subjects_affected="77" subjects_at_risk="143"/>
                <counts group_id="E3" events="150" subjects_affected="75" subjects_at_risk="126"/>
              </event>
              <event>
                <sub_title>Dizziness/Fainting</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="139"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="143"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="126"/>
              </event>
              <event>
                <sub_title>Other</sub_title>
                <counts group_id="E1" events="59" subjects_affected="42" subjects_at_risk="139"/>
                <counts group_id="E2" events="89" subjects_affected="47" subjects_at_risk="143"/>
                <counts group_id="E3" events="48" subjects_affected="28" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Muscle soreness or pain that persists for more than 48 hours</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="139"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="143"/>
                <counts group_id="E3" events="10" subjects_affected="10" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dyspnea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="139"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="143"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="126"/>
              </event>
              <event>
                <sub_title>Diaphoretic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="139"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="143"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Open sore or blister, cuts</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="139"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="143"/>
                <counts group_id="E3" events="12" subjects_affected="11" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>DVT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="139"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="143"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Pamela W. Duncan, PT, PhD, FAHA, FAPTA</name_or_title>
      <organization>Duke University</organization>
      <phone>919-681-2060</phone>
      <email>pamela.duncan@duke.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

